Hints on the Lateralization of Dopamine Binding to D1 Receptors in Rat Striatum
Jazyk angličtina Země Spojené státy americké Médium print-electronic
Typ dokumentu časopisecké články, práce podpořená grantem
PubMed
26452359
DOI
10.1007/s12035-015-9468-8
PII: 10.1007/s12035-015-9468-8
Knihovny.cz E-zdroje
- Klíčová slova
- 6-hydroxydopamine, Basal ganglia, Cooperativity index, Dyskinesia, G-protein-coupled receptor dimer, Lateralization,
- MeSH
- 2,3,4,5-tetrahydro-7,8-dihydroxy-1-fenyl-1H-3-benzazepin farmakologie MeSH
- benzazepiny farmakologie MeSH
- corpus striatum metabolismus MeSH
- dopamin metabolismus MeSH
- funkční lateralita * účinky léků MeSH
- polékové dyskineze metabolismus MeSH
- potkani Wistar MeSH
- receptory dopaminu D1 metabolismus MeSH
- receptory dopaminu D3 agonisté metabolismus MeSH
- zvířata MeSH
- Check Tag
- mužské pohlaví MeSH
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- Názvy látek
- 2,3,4,5-tetrahydro-7,8-dihydroxy-1-fenyl-1H-3-benzazepin MeSH
- benzazepiny MeSH
- dopamin MeSH
- receptory dopaminu D1 MeSH
- receptory dopaminu D3 MeSH
- SCH 23390 MeSH Prohlížeč
Dopamine receptors in striatum are important for healthy brain functioning and are the target of levodopa-based therapy in Parkinson's disease. Lateralization of dopaminergic neurotransmission in striata from different hemispheres occurs in patients, but also in healthy individuals. Our data show that the affinity of dopamine binding to dopamine D1 receptors is significantly higher in left than in right striatum. Analysis of data from radioligand binding to striatal samples from naïve, 6-hydroxydopamine lesioned, levodopa-treated and levodopa-induced dyskinetic rats shows differential receptor structure and gives hints on the causes of right/left lateralization of dopamine binding to striatal D1 receptors. Moreover, binding data showed loss of lateralization in levodopa (L-DOPA)-induced dyskinetic rats.
Institute of Physiology Academy of Sciences Videnska 1083 14220 Prague Czech Republic
School of Pharmacy and Biomedical Sciences University of Central Lancashire PR1 2HE Preston UK
Zobrazit více v PubMed
Pharmacol Ther. 2007 Dec;116(3):343-54 PubMed
J Biol Chem. 2004 Aug 20;279(34):35671-8 PubMed
FASEB J. 2011 Oct;25(10):3465-76 PubMed
Mov Disord. 1998 Sep;13(5):788-97 PubMed
Neuroreport. 2014 Oct 22;25(15):1191-7 PubMed
J Neurosci. 2001 Aug 15;21(16):6252-63 PubMed
Neuropsychobiology. 2001;43(3):192-9 PubMed
Neuropharmacology. 2015 Oct;97:365-75 PubMed
J Biol Chem. 2003 May 30;278(22):20196-202 PubMed
Brain. 2009 May;132(Pt 5):1366-75 PubMed
J Mol Signal. 2013 Dec 05;8(1):13 PubMed
Proc Natl Acad Sci U S A. 2000 Jul 18;97(15):8606-11 PubMed
Mol Pharmacol. 2013 Aug;84(2):190-200 PubMed
PLoS One. 2011 Jan 11;6(1):e16088 PubMed
Neuropharmacology. 2014 Apr;79:688-706 PubMed
Eur J Neurosci. 1998 Aug;10(8):2694-706 PubMed
Mol Pharmacol. 2005 Feb;67(2):460-9 PubMed
Nucl Med Commun. 1998 Aug;19(8):781-7 PubMed
Synapse. 1988;2(5):546-57 PubMed
Arch Gen Psychiatry. 2003 Mar;60(3):311-9 PubMed
J Biol Chem. 2007 Oct 12;282(41):30062-9 PubMed
Biochem Pharmacol. 2009 Dec 15;78(12):1456-63 PubMed
Eur J Neurosci. 2011 May;33(9):1706-15 PubMed
J Neurosci Res. 1990 Aug;26(4):461-73 PubMed
Life Sci. 1982 Jun 21;30(25):2155-62 PubMed
Int J Mol Sci. 2014 May 14;15(5):8570-90 PubMed
Brain Res. 1988 Jul 5;455(1):43-8 PubMed
Cell. 2002 Oct 18;111(2):219-30 PubMed
Mol Pharmacol. 2006 Jun;69(6):1905-12 PubMed
Brain Res Mol Brain Res. 2001 Mar 5;87(2):271-9 PubMed
Prog Mol Biol Transl Sci. 2010;91:41-52 PubMed
Eur J Pharmacol. 2001 Sep 21;427(3):187-93 PubMed
Brain Res. 1982 Feb 18;234(1):53-63 PubMed
Proc Natl Acad Sci U S A. 2007 Jan 9;104(2):654-9 PubMed
Front Psychol. 2013 Dec 11;4:939 PubMed
Eur Neuropsychopharmacol. 2015 Sep;25(9):1470-9 PubMed
Anat Embryol (Berl). 1994 Aug;190(2):181-94 PubMed
Biol Psychol. 2008 Jan;77(1):98-101 PubMed
Mol Neurobiol. 2015 Dec;52(3):1408-1420 PubMed
J Neurosci Methods. 2005 Feb 15;141(2):251-60 PubMed
J Biol Chem. 2010 Aug 27;285(35):27346-59 PubMed
Neuropsychopharmacology. 2009 Apr;34(5):1277-87 PubMed
Neuropharmacology. 2007 Mar;52(3):1003-14 PubMed
PLoS One. 2013 Sep 06;8(9):e74512 PubMed
J Neurochem. 2001 Sep;78(5):981-90 PubMed
Neuron. 2008 May 22;58(4):557-70 PubMed
Exp Neurobiol. 2015 Mar;24(1):90-4 PubMed
J Cogn Neurosci. 2014 May;26(5):1039-48 PubMed
Nat Chem Biol. 2009 Mar;5(3):131-4 PubMed